Want to join the conversation?
$PFE 2Q15 Q&A: Anderson of Bernstein asked an update on Enbrel. Geno replied that Enbrel continues to do well, 2% operational growth outside US on a large base. Overall, the company is not seeing or expecting a major shift in the Enbrel business related to the Remicade biosimilar, added Geno.
Any idea why some investors are happy about the disastrous $UA results??
Wow! GM killed it with earnings today! Did not expect this after $F gave the feeling it will eclipse the Chevy maker completely!
Oil rebound starting to show up in energy stocks. $XOM $CVX
I have a feeling "CLOUDy" days are ahead, with $AMZN leading the pack.
$AAL is giving pay hikes to its employees but investors are sulking.